Xponential Fitness, Inc. XPOF
We take great care to ensure that the data presented and summarized in this overview for Xponential Fitness, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding XPOF
View all-
Nut Tree Capital Management, LP New York, NY3MShares$48.1 Million10.26% of portfolio
-
Voss Capital, LLC Houston, TX2.84MShares$45.5 Million3.35% of portfolio
-
Msd Partners, L.P. New York, NY1.76MShares$28.3 Million31.17% of portfolio
-
Black Rock Inc. New York, NY1.74MShares$27.9 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.62MShares$26 Million0.01% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.47MShares$23.5 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$23.2 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.15MShares$18.5 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD990KShares$15.9 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY879KShares$14.1 Million0.0% of portfolio
Latest Institutional Activity in XPOF
Top Purchases
Top Sells
About XPOF
Xponential Fitness, Inc., through its subsidiaries, operates as a boutique fitness franchisor in the United States and internationally. The company offers fitness and wellness services, including pilates, barre, cycling, stretching, rowing, yoga, boxing, dancing, running, and functional training under the Club Pilates, Pure Barre, CycleBar, StretchLab, Row House, YogaSix, Rumble, AKT, Stride, and BFT brands. As of December 31, 2021, it had 1,556 franchisees operating 1,954 open studios on an adjusted basis. The company was founded in 2017 and is headquartered in Irvine, California.
Insider Transactions at XPOF
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 01
2025
|
Jeffrey D Lawrence Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,911
+11.78%
|
-
|
|
Jan 01
2025
|
Bruce N Haase Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,874
+23.74%
|
-
|
|
Jan 01
2025
|
Mark Grabowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,480
+6.98%
|
-
|
|
Nov 21
2024
|
Mark Grabowski Director |
SELL
Open market or private sale
|
Indirect |
2,595,598
-59.07%
|
$38,933,970
$15.35 P/Share
|
|
Nov 21
2024
|
Mark Grabowski Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,352,047
+50.0%
|
-
|
|
Nov 21
2024
|
Mark Grabowski Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,352,047
-18.14%
|
-
|
|
Nov 16
2024
|
Bruce N Haase Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,146
+50.0%
|
-
|
|
Oct 10
2024
|
Andrew Hagopian Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
26,740
-9.47%
|
$320,880
$12.18 P/Share
|
|
Oct 01
2024
|
Mark Grabowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,645
+7.97%
|
-
|
|
Oct 01
2024
|
Jeffrey D Lawrence Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,037
+14.1%
|
-
|
|
Sep 13
2024
|
Sarah Luna President |
SELL
Open market or private sale
|
Direct |
14,400
-4.73%
|
$187,200
$13.85 P/Share
|
|
Jun 17
2024
|
Mark James King Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
323,749
+41.67%
|
-
|
|
Jun 17
2024
|
Brenda I Morris Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,249
+8.35%
|
-
|
|
May 31
2024
|
John P Meloun Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,346
+16.36%
|
-
|
|
May 31
2024
|
Sarah Luna President |
BUY
Grant, award, or other acquisition
|
Direct |
55,346
+15.37%
|
-
|
|
May 31
2024
|
Andrew Hagopian Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,346
+16.44%
|
-
|
|
May 31
2024
|
Brenda I Morris Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,855
+15.23%
|
-
|
|
May 30
2024
|
Chelsea A Grayson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,888
+30.27%
|
-
|
|
May 30
2024
|
Jeffrey D Lawrence Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,888
+48.81%
|
-
|
|
May 30
2024
|
Jair Clarke Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,888
+37.32%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 671K shares |
|---|---|
| Exercise of conversion of derivative security | 1.35M shares |
| Open market or private sale | 2.74M shares |
|---|---|
| Sale (or disposition) back to the issuer | 1.35M shares |